🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
1.290
-0.130 (-9.15%)
At close: Nov 20, 2026, 4:00 PM EST
1.310
+0.020 (1.55%)
After-hours: Nov 20, 2026, 7:41 PM EST

Quantum BioPharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.561.9162.7616.9835.26
Short-Term Investments
0.20.461.20.76-0.16
Cash & Short-Term Investments
3.762.367.23.5116.9835.42
Cash Growth
247.14%-67.15%104.89%-79.31%-52.06%102.10%
Accounts Receivable
--3.437.190.02-
Other Receivables
0.570.230.370.230.370.5
Receivables
0.570.233.817.420.40.5
Inventory
-0.050.12---
Prepaid Expenses
0.040.020.040.120.160.76
Other Current Assets
8.663.820.890.030.319.25
Total Current Assets
13.036.4812.0511.0917.8545.93
Property, Plant & Equipment
0.10.170.130.120.260.17
Long-Term Investments
--00.010.830.66
Other Intangible Assets
4.24.514.935.3612.0416.2
Long-Term Accounts Receivable
---0.917.43-
Total Assets
17.3311.1617.1217.4738.4162.96

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.781.983.253.242.763
Accrued Expenses
-2.21.110.954.354.46
Short-Term Debt
0.31.30.620.30.30.3
Current Portion of Long-Term Debt
0.580.470.15---
Current Portion of Leases
0.050.10.050.040.180.12
Current Unearned Revenue
--1---
Other Current Liabilities
2.85-0.490.030.240.83
Total Current Liabilities
7.566.066.684.577.838.7
Long-Term Leases
----0.040.13
Total Liabilities
7.566.066.684.577.878.83

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
191.68169.7150.47137.78143.41152.32
Additional Paid-In Capital
35.3835.4131.0730.2328.522.58
Retained Earnings
-215.4-198.29-172.11-157.91-144.16-126.15
Comprehensive Income & Other
0.140.12.053.142.85.38
Total Common Equity
11.86.9211.4813.2430.5454.13
Minority Interest
-2.03-1.82-1.04-0.33--
Shareholders' Equity
9.775.110.4412.9130.5454.13
Total Liabilities & Equity
17.3311.1617.1217.4738.4162.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.921.880.820.340.520.56
Net Cash (Debt)
2.830.496.373.1716.4634.86
Net Cash Growth
--92.34%100.80%-80.72%-52.77%104.90%
Net Cash Per Share
0.490.155.615.2127.6364.84
Filing Date Shares Outstanding
7.985.832.710.620.630.59
Total Common Shares Outstanding
7.983.892.30.610.590.62
Working Capital
5.470.425.376.5210.0237.23
Book Value Per Share
1.481.784.9921.8551.5686.98
Tangible Book Value
7.62.416.557.8818.537.93
Tangible Book Value Per Share
0.950.622.8513.0131.2360.95
SEC Filings: 10-K · 10-Q